Nevertheless, the limitations of this study might include 1) as a single-center study conducted at our institution, it has a relatively small sample size and inherent selection bias and 2) further experiments are needed to elucidate the specific mechanisms by which BATF and EGR1 regulate immune checkpoint genes in AML patients. Here, EGR1 is linked to acute myeloid leukemia.